Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen
Shao-liang
SL
Cardiological Division, Nanjing First Hospital of Nanjing Medical University, Nanjing 210006, China. chmengx@126.com
Ye
Fei
F
Xu
Zu-ling
ZL
Lin
Song
S
Duan
Bao-xiang
BX
Dai
Zhen-ling
ZL
Shan
Shou-jie
SJ
Zhang
Jun-jie
JJ
D000328:Adult; D000368:Aged; D002037:Bundle-Branch Block / Q000209:etiology; D002312:Cardiomyopathy, Hypertrophic / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006346:Heart Septum / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology